tracken
Chemours Co. Aktie News
Neutral
Accesswire
●
etwa 4 Stunden alt
NEW YORK, NY / ACCESSWIRE / May 1, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=77772&wire=1 or contact Joseph E. Levi, Esq.
Neutral
PRNewsWire
●
etwa 6 Stunden alt
RADNOR, Pa. , May 1, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between February 10, 2023 and February 28, 2024, inclusive (the "Class Peri...
Neutral
Seeking Alpha
●
etwa 11 Stunden alt
Chemours Co (NYSE:CC ) Q1 2024 Results Conference Call May 1, 2024 8:00 AM ET Company Participants Brandon Ontjes - Vice President of Investor Relations Denise Dignam - President and Chief Executive Officer Matt Abbott - Chief Financial Officer Conference Call Participants Duffy Fischer - Goldman Sachs John McNulty - BMO Capital Markets Josh Spector - UBS Financial Hassan Ahmed - Alembic Global...
Neutral
Accesswire
●
etwa 12 Stunden alt
NEW YORK, NY / ACCESSWIRE / May 1, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=77719&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
●
etwa 17 Stunden alt
NEW YORK, NY / ACCESSWIRE / May 1, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=77671&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
●
etwa 19 Stunden alt
NEW YORK, NY / ACCESSWIRE / May 1, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=77663&wire=1 or contact Joseph E. Levi, Esq.
Neutral
PRNewsWire
●
etwa 20 Stunden alt
LOS ANGELES , May 1, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors wh...
Neutral
Accesswire
●
etwa 23 Stunden alt
NEW YORK, NY / ACCESSWIRE / April 30, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=77658&wire=1 or contact Joseph E. Levi, Esq.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
